biote Corp
NASDAQ:BTMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shradha Infraprojects Ltd
NSE:SHRADHA
|
IN |
biote Corp
Total Liabilities
biote Corp
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
b
|
biote Corp
NASDAQ:BTMD
|
Total Liabilities
$166.2m
|
CAGR 3-Years
2%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Liabilities
$117.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
6%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Liabilities
$71.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
15%
|
|
|
Pfizer Inc
NYSE:PFE
|
Total Liabilities
$121.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Total Liabilities
$84.3B
|
CAGR 3-Years
10%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Liabilities
$85.9B
|
CAGR 3-Years
30%
|
CAGR 5-Years
16%
|
CAGR 10-Years
15%
|
|
biote Corp
Glance View
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas. The company went IPO on 2021-03-02. The firm provides components to enable Biote-certified practitioners to establish, build, and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. Its Biote Method is a comprehensive, end-to-end practice-building platform that provides Biote-certified practitioners with components specifically developed for practitioners in the hormone optimization space, such as Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The firm trains practitioners how to identify and treat early indicators of hormone-related aging conditions. The company also sells a complementary Biote-branded line of dietary supplements.
See Also
What is biote Corp's Total Liabilities?
Total Liabilities
166.2m
USD
Based on the financial report for Dec 31, 2025, biote Corp's Total Liabilities amounts to 166.2m USD.
What is biote Corp's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
27%
Over the last year, the Total Liabilities growth was -27%. The average annual Total Liabilities growth rates for biote Corp have been 2% over the past three years , 27% over the past five years .